UBS Group
PRLB icon

UBS Group’s Protolabs PRLB Stock Holding History

UBS Group’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,500
Closed -$745K – 7890
2016
Q4 		$745K Sell
14,500
-45,500
-76% -$2.39M ﹤0.01% 3804
2016
Q3 		$3.6M Buy
+60,000
New +$3.45M ﹤0.01% 2327

Other funds holding PRLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

UBS Group's PRLB Position: Q2 2026 in Review

UBS Group reduced its Protolabs (PRLB) stake by 42% in Q2 2026, selling an estimated $5.03M and leaving 97,304 shares worth $7.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3701.

UBS Group first reported a position in PRLB in Q4 2014 and has held it in 47 quarters since. The position peaked at $9.68M in Q2 2025. 277 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • UBS Group held 97,304 shares of Protolabs worth $7.93M as of Q2 2026.
  • UBS Group sold 71,446 Protolabs shares in Q2 2026, an estimated $5.03M.
  • Protolabs made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3701 holding.
  • UBS Group first reported a position in Protolabs in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Protolabs position peaked at $9.68M in Q2 2025.
  • 277 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.